Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse GHRHR ELISA Kit (AC2911)
Cat.#: ASET-1500
Specifications
Description Mouse GHRHR ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse GHRHR concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.06 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1978 Bovine TIMP1 ELISA Kit (AC3389) Quantitative inquiry ASET-1639 Human Ataxin 1 ELISA Kit (AC3050) Quantitative inquiry ASET-1496 Porcine Neuropeptide Y ELISA Kit (AC2907) Quantitative inquiry ASET-1376 Human TPP1 ELISA Kit (AC2787) Quantitative inquiry ASET-1913 Rat Tau ELISA Kit (AC3324) Quantitative inquiry ASET-2271 Human PKC delta ELISA Kit (AC3682) Quantitative inquiry ASET-2478 Human RAMP1 ELISA Kit (AC3889) Quantitative inquiry ASET-2337 Human GLP1 ELISA Kit (AC3748) Quantitative inquiry ASET-2050 Human MAL ELISA Kit (AC3461) Quantitative inquiry ASET-2019 Rat CD45 ELISA Kit (AC3430) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket